What Happened?

About the Company

TriLink BioTechnologies, part of Maravai LifeSciences, is a prominent contract development and manufacturing organization (CDMO) based in San Diego. Founded in 1996, the company specializes in the synthesis of nucleic acids, nucleoside triphosphates (NTPs), and mRNA capping analogs. TriLink provides advanced scale-up expertise and unique production capabilities for mRNA, oligonucleotides, and plasmids, catering to clients in therapeutics, vaccines, diagnostics, and biopharmaceutical innovations. The company offers custom synthesis and manufacturing services, supporting clients from early research through clinical trials. TriLinks proprietary CleanCap® technology enhances mRNA manufacturing efficiency, resulting in improved yields. Their product portfolio includes custom and modified oligonucleotides, plasmids, mRNA, and CleanCap® reagents. TriLink adheres to stringent quality systems compliant with ICH Q7, GMP guidelines, and ISO 9001:2015 standards, ensuring high-quality manufacturing for a diverse range of applications. The company collaborates with various organizations, including the U.S. Department of Defense, to support the development of critical mRNA vaccines and therapeutics.

About the Person